Vadivarhe Speciality Chemicals Limited, formed in 2009, inherited the Speciality Chemical Division of Fem Care Pharma Ltd, following its acquisition by Dabur India Limited. Under the leadership of promoter Sunil Haripant Pophale, the company focuses on producing speciality chemicals, Active Pharmaceutical Ingredients (APIs), intermediates, and personal care products. It launched API manufacturing in 2010 and briefly engaged in the nutraceutical trading business. The company went public in 2017, raising Rs. 14.46 Crores through an Initial Public Offering.
Located in Nashik, Vadivarhe Speciality Chemicals is ISO 9001:2015 certified and holds a WHO-GMP certificate for its API manufacturing. Its clientele includes prominent names like GlaxoSmithKline Pharmaceuticals, Lupin Ltd, and Mankind Pharma Limited, serving both domestic and international markets. The company stands out for its expertise in organic chemicals and custom synthesis.
